NantHealth (NASDAQ:NH – Get Free Report) and QXO (NASDAQ:QXO – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, institutional ownership, valuation, dividends, analyst recommendations, earnings and profitability.
Risk & Volatility
NantHealth has a beta of 1.82, meaning that its share price is 82% more volatile than the S&P 500. Comparatively, QXO has a beta of 2.34, meaning that its share price is 134% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for NantHealth and QXO, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| NantHealth | 0 | 0 | 0 | 0 | 0.00 |
| QXO | 0 | 0 | 10 | 2 | 3.17 |
Institutional and Insider Ownership
4.5% of NantHealth shares are held by institutional investors. Comparatively, 58.7% of QXO shares are held by institutional investors. 61.3% of NantHealth shares are held by company insiders. Comparatively, 51.3% of QXO shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares NantHealth and QXO’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| NantHealth | -94.67% | N/A | -39.82% |
| QXO | 30.08% | 1.58% | 1.30% |
Valuation and Earnings
This table compares NantHealth and QXO”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| NantHealth | $67.68 million | 0.00 | -$67.78 million | ($7.65) | 0.00 |
| QXO | $1.95 billion | 7.22 | -$1.07 million | ($0.21) | -99.41 |
QXO has higher revenue and earnings than NantHealth. QXO is trading at a lower price-to-earnings ratio than NantHealth, indicating that it is currently the more affordable of the two stocks.
Summary
QXO beats NantHealth on 13 of the 15 factors compared between the two stocks.
About NantHealth
NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.
About QXO
QXO, Inc. operates as a business application, technology, and consulting company in North America. The company provides solutions for accounting and business management, financial reporting, enterprise resource planning, human capital management, warehouse management systems, customer relationship management, and business intelligence. It also offers value-added services that focuses on consulting and professional, specialized programming, training, and technical support services. In addition, the company provides information technology managed services, such as cybersecurity, application hosting, disaster recovery, business continuity, cloud, and other services; and data back-up, network maintenance, and upgrade services. It serves small and medium-sized businesses primarily in the manufacturing, distribution, and service industries. QXO, Inc. is headquartered in Greenwich, Connecticut.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.
